While medicine has become more advanced and specialized, it has also become increasingly fragmented. For people is hard-to-diagnose conditions, that's another obstacle to care.
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.